CRITICAL CARE PORTFOLIO

You are here:
  • Critical Care

    Meropik-SE

    Meropenem 1gm+Sulbactum 500mg +EDTA 37.5MG

    Meropenem is a broad-spectrum Carbapenems with activity against Gram-positive and Gram-negative bacteria and anaerobic bacteria. Sulbactam is a beta lactamase inhibitor. It is given in combination with beta lactam antibiotics to inhibit beta lactamase, an enzyme produced by bacteria that destroys the antibiotics. Meropenem and sulbactam in combination exhibit synergistic activity. Ethylenediaminetetraacetic acid (EDTA) is…

    Know More